Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Shares Outstanding (Weighted Average) (2017 - 2024)

Historic Shares Outstanding (Weighted Average) for Solid Biosciences (SLDB) over the last 8 years, with Q3 2024 value amounting to $41.4 million.

  • Solid Biosciences' Shares Outstanding (Weighted Average) rose 10660.05% to $41.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $41.4 million, marking a year-over-year increase of 10660.05%. This contributed to the annual value of $19.9 million for FY2023, which is 13359.73% up from last year.
  • Latest data reveals that Solid Biosciences reported Shares Outstanding (Weighted Average) of $41.4 million as of Q3 2024, which was up 10660.05% from $40.9 million recorded in Q2 2024.
  • In the past 5 years, Solid Biosciences' Shares Outstanding (Weighted Average) ranged from a high of $112.3 million in Q2 2021 and a low of $3.5 million during Q4 2020
  • For the 5-year period, Solid Biosciences' Shares Outstanding (Weighted Average) averaged around $31.3 million, with its median value being $19.9 million (2023).
  • As far as peak fluctuations go, Solid Biosciences' Shares Outstanding (Weighted Average) tumbled by 9330.01% in 2022, and later surged by 16630.06% in 2023.
  • Quarter analysis of 5 years shows Solid Biosciences' Shares Outstanding (Weighted Average) stood at $3.5 million in 2020, then surged by 105.58% to $7.1 million in 2021, then grew by 19.58% to $8.5 million in 2022, then surged by 133.6% to $19.9 million in 2023, then soared by 108.43% to $41.4 million in 2024.
  • Its Shares Outstanding (Weighted Average) stands at $41.4 million for Q3 2024, versus $40.9 million for Q2 2024 and $38.2 million for Q1 2024.